CAS: 1702259-66-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | H3B-6527 REF: IN-DA00ABSCCAS: 1702259-66-2 | 97% | To inquire | Mon 02 Dec 24 |
 | H3B-6527 REF: TM-T7738CAS: 1702259-66-2 | 97.45% | 69.00 €~1,040.00 € | Tue 10 Dec 24 |
 | H3B-6527 REF: 3D-CTC25966CAS: 1702259-66-2 | Min. 95% | To inquire | Mon 13 Jan 25 |
H3B-6527
CAS:1702259-66-2
Formula:
C29H34Cl2N8O4
Purity:
97%
Color and Shape:
Solid
Molecular weight:
629.5375
Ref: IN-DA00ABSC
| 1mg | 169.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 490.00 € | ||
| 50mg | 587.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
H3B-6527
CAS:1702259-66-2
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma, with antineoplastic …
Formula:
C29H34Cl2N8O4
Purity:
97.45%
Color and Shape:
Solid
Molecular weight:
629.54
Ref: TM-T7738
| 1mg | 69.00 € | ||
| 5mg | 165.00 € | ||
| 10mg | 268.00 € | ||
| 25mg | 518.00 € | ||
| 50mg | 732.00 € | ||
| 100mg | 1,040.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
H3B-6527
CAS:1702259-66-2
H3B-6527 is a novel, potent and reversible CDK4/6 inhibitor that has been shown to inhibit …
Formula:
C29H34Cl2N8O4
Purity:
Min. 95%
Molecular weight:
629.54 g/mol
Ref: 3D-CTC25966
| 1mg | To inquire | ||
| 10mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
